Powder: -20°C for 3 years | In solvent: -80°C for 1 year
MS049 是一种有效的、选择性的和细胞活性的 PRMT4 和 PRMT6 双重抑制剂,IC50 分别为 34 和 43 nM。它可降低 HEK293 细胞的 Med12me2a 和 H3R2me2a 水平。
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
1 mg | ¥ 237 | 现货 | ||
5 mg | ¥ 533 | 现货 | ||
10 mg | ¥ 898 | 现货 | ||
25 mg | ¥ 1,990 | 现货 | ||
50 mg | ¥ 3,660 | 现货 | ||
100 mg | ¥ 5,360 | 现货 | ||
200 mg | ¥ 7,550 | 现货 | ||
1 mL * 10 mM (in DMSO) | ¥ 533 | 现货 |
产品描述 | MS 049 is a potent, selective, and cell-active dual inhibitor of PRMT4 and PRMT6 with IC 50 of 34 nM and 43 nM, respectively. |
靶点活性 | PRMT4:34 nM, PRMT6:43 nM |
体外活性 | In cellular assays, MS049 potently inhibits the methyltransferase activity of PRMT4 and PRMT6 and reduces levels of Med12me2a and H3R2me2a in HEK293 cells. MS049 does not inhibit any of the methyltransferases at 50 μM or demethylases at 10 μM and does not display appreciable binding to any of the methyllysine/methylarginine reader proteins using the DSF assay at 200 μM. |
细胞实验 | HEK293 cells grown in DMEM supplemented with 10% FBS, penicillin (100 U/mL), and streptomycin (100 μg/mL) were seeded on 96-well plates at density 3000/well and treated with compounds at 0, 1, 10, and 50 μM concentrations for 96 h. The confluency was measured using IncuCyte ZOOM live cell imaging device and analyzed with IncuCyte ZOOM software based on phase contrast images. |
分子量 | 248.36 |
分子式 | C15H24N2O |
CAS No. | 1502816-23-0 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 55 mg/mL (221.45 mM)
可选溶剂 | 浓度 体积 质量 | 1 mg | 5 mg | 10 mg | 25 mg |
DMSO | 1 mM | 4.0264 mL | 20.1321 mL | 40.2641 mL | 100.6603 mL |
5 mM | 0.8053 mL | 4.0264 mL | 8.0528 mL | 20.1321 mL | |
10 mM | 0.4026 mL | 2.0132 mL | 4.0264 mL | 10.066 mL | |
20 mM | 0.2013 mL | 1.0066 mL | 2.0132 mL | 5.033 mL | |
50 mM | 0.0805 mL | 0.4026 mL | 0.8053 mL | 2.0132 mL | |
100 mM | 0.0403 mL | 0.2013 mL | 0.4026 mL | 1.0066 mL |
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
MS049 1502816-23-0 Chromatin/Epigenetic Histone Methyltransferase arginine HEK293 dimethylation MS 049 Inhibitor toxic H4R3me2a inhibit selective epigenetic MS-049 cells modifiers inhibitor